13-ID-198: A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio cholerae O1 Serotype Inaba Vaccine S

Grants and Contracts Details

StatusFinished
Effective start/end date11/11/13 → 10/31/16

Funding

  • PaxVax Incorporated: $67,182.00